{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:55:29Z","timestamp":1776423329315,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondazione Buzzi Unicem (Casale Monferrato, Italy)","award":["FBU-P27"],"award-info":[{"award-number":["FBU-P27"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.taap.2013.10.025","type":"journal-article","created":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T15:52:52Z","timestamp":1383580372000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Combination of ascorbate\/epigallocatechin-3-gallate\/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells"],"prefix":"10.1016","volume":"274","author":[{"given":"Simona","family":"Martinotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-8215","authenticated-orcid":false,"given":"Elia","family":"Ranzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Burlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2013.10.025_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3816\/CLC.2004.n.008","article-title":"Integration of multimodality approaches in the management of malignant pleural mesothelioma","volume":"5","author":"Martino","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.taap.2013.10.025_bb0010","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2013.10.025_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/sonc.2002.30232","article-title":"The role of gemcitabine in the treatment of malignant mesothelioma","volume":"29","author":"Kindler","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.taap.2013.10.025_bb0020","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1745-7254.2007.00689.x","article-title":"Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy","volume":"28","author":"Sarkar","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2013.10.025_bb0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/annonc\/mdg207","article-title":"Adjuvant therapy in pancreatic cancer: historical and current perspectives","volume":"14","author":"Neoptolemos","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2013.10.025_bb0030","first-page":"809","article-title":"High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer","volume":"29","author":"Ohno","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2013.10.025_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1165\/rcmb.2009-0340OC","article-title":"Selective ascorbate toxicity in malignant mesothelioma: a redox Trojan mechanism","volume":"44","author":"Ranzato","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.taap.2013.10.025_bb0040","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.tiv.2011.05.023","article-title":"In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma","volume":"25","author":"Martinotti","year":"2011","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2013.10.025_bb0045","doi-asserted-by":"crossref","first-page":"e58051","DOI":"10.1371\/journal.pone.0058051","article-title":"Preclinical demonstration of synergistic active nutrients\/drug (AND) combination as a potential treatment for malignant pleural mesothelioma","volume":"8","author":"Volta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2013.10.025_bb0050","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1038\/sj.onc.1207353","article-title":"Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis","volume":"23","author":"Gupta","year":"2004","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.taap.2013.10.025_bb0055","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1111\/j.1582-4934.2012.01584.x","article-title":"Epigallocatechin-3-gallate induces mesothelioma cell death via H(2)O(2)-dependent T-type Ca(2+) channel opening","volume":"6","author":"Ranzato","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2013.10.025_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-07-1388","article-title":"Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts","volume":"14","author":"Bertino","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2013.10.025_bb0065","first-page":"2055","article-title":"Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system","volume":"54","author":"Smythe","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2013.10.025_bb0070","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/jcb.22316","article-title":"Spreading of mesothelioma cells is rapamycin-sensitive and requires continuing translation","volume":"108","author":"Ranzato","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.taap.2013.10.025_bb0075","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1038\/sj.onc.1202701","article-title":"Death-associated protein kinase 2 is a new calcium\/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity","volume":"18","author":"Kawai","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2013.10.025_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/CJI.0b013e31819f1cb6","article-title":"Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells","volume":"32","author":"Tur","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.taap.2013.10.025_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.2009.08040.x","article-title":"Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2","volume":"149","author":"Britschgi","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.taap.2013.10.025_bb0090","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1096\/fj.06-6239com","article-title":"Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance","volume":"20","author":"Giroux","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2013.10.025_bb0095","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2006-05-022814","article-title":"Specific killing of multiple myeloma cells by (\u2212)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications","volume":"108","author":"Shammas MA","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.taap.2013.10.025_bb0100","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2013.10.025_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-006-9322-9","article-title":"Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance","volume":"102","author":"Hernandez-Vargas","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.taap.2013.10.025_bb0110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08830180802317957","article-title":"Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli","volume":"27","author":"Krakauer","year":"2008","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.taap.2013.10.025_bb0115","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bcp.2010.06.044","article-title":"Expression, biological activities and mechanisms of action of A20 (TNFAIP3)","volume":"80","author":"Verstrepen","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.025_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-008-9952-9","article-title":"A simultaneous release of SOD1 with cytochrome c regulates mitochondria-dependent apoptosis","volume":"322","author":"Li","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2013.10.025_bb0125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jcp.22001","article-title":"Akt-1 mediates survival of chondrocytes from endoplasmic reticulum-induced stress","volume":"222","author":"Price","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2013.10.025_bb0130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.biocel.2008.08.006","article-title":"Endoplasmic reticulum stress underlying the pro-apoptotic effect of epigallocatechin gallate in mouse hepatoma cells","volume":"41","author":"Magyar","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.taap.2013.10.025_bb0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbamcr.2010.10.010","article-title":"Anti-apoptosis and cell survival: a review","volume":"1813","author":"Portt","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2013.10.025_bb0140","first-page":"661","article-title":"Black tea polyphenols restrict benzopyrene-induced mouse lung cancer progression through inhibition of Cox-2 and induction of caspase-3 expression","volume":"7","author":"Banerjee","year":"2006","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.taap.2013.10.025_bb0145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00125-009-1331-x","article-title":"Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line","volume":"52","author":"Sarkar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.taap.2013.10.025_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1568011033353452","article-title":"Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy","volume":"3","author":"Shinkaruk","year":"2003","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.taap.2013.10.025_bb0155","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1158\/1078-0432.CCR-08-1032","article-title":"Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review. Clinical cancer research","volume":"14","author":"Morgan","year":"2008","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.taap.2013.10.025_bb0160","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","article-title":"AP-1 in cell proliferation and survival","volume":"20","author":"Shaulian","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2013.10.025_bb0165","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/jcb.20656","article-title":"Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis","volume":"96","author":"Marlowe","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.taap.2013.10.025_bb0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mc.20584","article-title":"E2F2 suppresses Myc-induced proliferation and tumorigenesis","volume":"49","author":"Pusapati","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.taap.2013.10.025_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ydbio.2010.07.023","article-title":"E2F1 and E2F2 have opposite effects on radiation-induced p53-independent apoptosis in Drosophila","volume":"346","author":"Wichmann","year":"2010","journal-title":"Dev. Biol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13004730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13004730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T06:23:45Z","timestamp":1716099825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X13004730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0041008X13004730"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2013.10.025","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of ascorbate\/epigallocatechin-3-gallate\/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2013.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}